Serological analysis of human tumor antigens: molecular definition and implications
Tài liệu tham khảo
van der Bruggen, 1991, A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma, Science, 254, 1643, 10.1126/science.1840703
Boon, 1994, Timor antigens recognized by T lymphocytes, Annu. Rev. Immunol, 12, 337, 10.1146/annurev.iy.12.040194.002005
Mandelboim, 1994, CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma, Nature, 369, 67, 10.1038/369067a0
Falk, 1991, Allele-specific motifs revealed by sequencing of selpeptides eluted from MHC molecules, Nature, 351, 290, 10.1038/351290a0
van Bleek, 1990, Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule, Nature, 348, 213, 10.1038/348213a0
Cox, 1994, Identification of a peptide recognized by five melanomaspecific human cytotoxic T-cell lines, Science, 264, 716, 10.1126/science.7513441
Brichard, 1993, The tyrosinase gene codes for an antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas, J. Exp. Med., 178, 489, 10.1084/jem.178.2.489
Coulie, 1994, A new gene coding for a differentiation antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas, J. Exp. Med., 180, 35, 10.1084/jem.180.1.35
Kawakami, 1994, Cloning of the gene coding for a differentiation antigen recognized by autologous T cells infiltrating into tumor, 91, 3515
Kawakami, 1994, Identification of the immunodominant peptide of the MART-1 human melanoma antigen recognized by the majority of HLAA2 restricted tumor infiltrating lymphocytes, J. Exp. Med., 180, 347, 10.1084/jem.180.1.347
Wölfel, 1995, A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma, Science, 269, 1281, 10.1126/science.7652577
1981, Cancer immunology: the search for specificity - G.H.A. Clowes Memorial Lecture, Cancer Res., 47, 261
Schlichtholz, 1994, Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein, Br. J. Cancer, 69, 809, 10.1038/bjc.1994.159
Disis, 1994, Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer, Cancer Res., 54, 16
Sahin, 1995, Human neoplasms elicit multiple specific immune responses in the autologous host, 92, 11810
Türeci, 1996, The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40, Cancer Res., 56, 4766
Türeci, 1997, Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease, J. Biol. Chem., 272, 6416, 10.1074/jbc.272.10.6416
Bilbe, 1992, Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease, EMBO J., 11, 2103, 10.1002/j.1460-2075.1992.tb05269.x
Brass, 1997, Translation initiation factor eIF-4γ is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma, Hum. Mol. Genet., 6, 33, 10.1093/hmg/6.1.33
Matzinger, 1994, Tolerance, danger, and the extended family, Annu. Rev. Immunol, 12, 991, 10.1146/annurev.iy.12.040194.005015
Chen, 1997, A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, 94, 1914
De Smet, 1994, Sequence and expression pattern of the human MAGE-2 gene, Immunogenetics, 39, 121, 10.1007/BF00188615
Gaugler, 1994, Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T-lymphocytes, J. Exp. Med., 179, 921, 10.1084/jem.179.3.921
Boel, 1995, BAGE: A new gene encoding an antigen recognized on human melanoma, Immunity, 2, 167, 10.1016/S1074-7613(95)80053-0
van den Eynde, 1995, A new family of genes coding for an antigen recognized by autologous cytolytic T-lymphocytes on a human melanoma, J. Exp. Med., 182, 689, 10.1084/jem.182.3.689
van den Eynde, 1991, The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice, J. Exp. Med., 173, 1373, 10.1084/jem.173.6.1373
Topalian, 1996, Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes, J. Exp. Med., 183, 1965, 10.1084/jem.183.5.1965
Bakker, 1994, Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes, J. Exp. Med., 179, 1005, 10.1084/jem.179.3.1005
Jäger, 1996, Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo, Int. J. Cancer, 66, 470, 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C
Yee, 1996, Isolation of tyrosinase specific CD8 positive and CD4 positive T-cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus, J. Immunol., 157, 4079, 10.4049/jimmunol.157.9.4079
